PSMA Theranostics: Current Status and Future Directions

PSMA Theranostics: Current Status and Future Directions

Prostate-specific membrane antigen (PSMA) is a promising target for imaging diagnostics and targeted radionuclide therapy (theranostics) of prostate cancer and its metastases. There is increasing evidence of encouraging response rates and a low toxicity profile of radioligand therapy (RLT) of metast...

Full description

Saved in:
Bibliographic Details
Main Authors: Kambiz Rahbar MD, Ali Afshar-Oromieh MD, Hossein Jadvar MD, PhD, Hojjat Ahmadzadehfar MD, MSc
Format: Article
Language:English
Published: SAGE Publishing 2018-06-01
Series:Molecular Imaging
Online Access:https://doi.org/10.1177/1536012118776068
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items